Similar to BRCA1, germline mutations in BRCA2 predispose patients to breast and ovarian cancer and genome instability (Wooster et al., 1995; Yu et al., 2000; Venkitaraman, 2002; King et al., 2003). This evidence concerns the gene BRCA1 and ovarian carcinoma.